GÖKÇE, M. Et Al. 2023. Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers. Gerontology , vol.69, no.9 , 1104-1112.

GÖKÇE, M., Velioglu, H. A., BEKTAY, M. Y., & Guler, E. M., (2023). Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers. Gerontology , vol.69, no.9, 1104-1112.

GÖKÇE, MUSTAFA Et Al. "Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers," Gerontology , vol.69, no.9, 1104-1112, 2023

GÖKÇE, MUSTAFA Et Al. "Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers." Gerontology , vol.69, no.9, pp.1104-1112, 2023

GÖKÇE, M. Et Al. (2023) . "Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers." Gerontology , vol.69, no.9, pp.1104-1112.

@article{article, author={MUSTAFA GÖKÇE Et Al. }, title={Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers}, journal={Gerontology}, year=2023, pages={1104-1112} }